Table 4 Univariate Cox-regression analyses for progression free survival.
Prognostic factor | HR | 95% CI | P-value (Wald-test) |
|---|---|---|---|
Stage | |||
I-II | 1 | ||
III-IV | 3.0 | 0.9–10.0 | 0.072 |
IPS | |||
0–2 | 1 | ||
3–7 | 4.12 | 1.3–13.1 | 0.016* |
Bulky disease | |||
Absent | 1 | ||
Present | 5.3 | 1.7–16.8 | 0.005** |
Necrosisvisual | |||
Absent | 1 | ||
Present | 2.8 | 0.8–9.4 | 0.096 |
SUVmax | |||
<Median | 1 | ||
≥Median | 0.7 | 0.2–2.1 | 0.49 |
SUVmean | |||
<Median | 1 | ||
≥Median | 0.5 | 0.2–1.7 | 0.28 |
SUVpeak | |||
<Median | 1 | ||
≥Median | 0.7 | 0.2–2.1 | 0.49 |
MTV | |||
<Median | 1 | ||
≥Median | 5.7 | 1.3–26.2 | 0.024* |
TLG | |||
<Median | 1 | ||
≥Median | 5.5 | 1.2–25.0 | 0.028* |
